Disease-modifying effects of ganglioside GM1 in Huntington's disease models.
Alpaugh M, Galleguillos D, Forero J, Morales LC, Lackey SW, Kar P, Di Pardo A, Holt A, Kerr BJ, Todd KG, Baker GB, Fouad K, Sipione S.
Alpaugh M, et al. Among authors: fouad k.
EMBO Mol Med. 2017 Nov;9(11):1537-1557. doi: 10.15252/emmm.201707763.
EMBO Mol Med. 2017.
PMID: 28993428
Free PMC article.